0001980845 us-gaap:WarrantMember 2026-07-17 2026-07-17 0001980845 2026-07-17 2026-07-17 0001980845 us-gaap:CommonStockMember 2026-07-17 2026-07-17 0001980845 false 00-0000000 8-K 2026-07-17 enGene Therapeutics Inc. A1 001-41854 4868 Rue Levy, Suite 220 Saint-Laurent QC CA H4R 2P1 514 332-4888 Not Applicable false false false false Common Shares ENGN NASDAQ Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per Common Share ENGNW NASDAQ true true